A detailed history of Logan Capital Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Logan Capital Management Inc holds 32,319 shares of LLY stock, worth $25.7 Million. This represents 1.22% of its overall portfolio holdings.

Number of Shares
32,319
Previous 32,447 0.39%
Holding current value
$25.7 Million
Previous $29.4 Million 2.53%
% of portfolio
1.22%
Previous 1.31%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 06, 2024

SELL
$772.14 - $960.02 $98,833 - $122,882
-128 Reduced 0.39%
32,319 $28.6 Million
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $44,941 - $56,360
-62 Reduced 0.19%
32,447 $29.4 Million
Q1 2024

May 13, 2024

SELL
$592.2 - $792.28 $53,298 - $71,305
-90 Reduced 0.28%
32,509 $25.3 Million
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $1.41 Million - $1.67 Million
-2,691 Reduced 7.63%
32,599 $19 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $131,279 - $180,988
302 Added 0.86%
35,290 $19 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $68,043 - $90,982
194 Added 0.56%
34,988 $16.4 Million
Q1 2023

May 12, 2023

BUY
$310.63 - $364.82 $104,682 - $122,944
337 Added 0.98%
34,794 $11.9 Million
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $1.36 Million - $1.58 Million
4,221 Added 13.96%
34,457 $12.6 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $1.32 Million - $1.5 Million
4,454 Added 17.28%
30,236 $9.78 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $44,970 - $55,808
200 Added 0.78%
25,782 $7.12 Million
Q1 2021

May 14, 2021

BUY
$164.32 - $212.72 $68,850 - $89,129
419 Added 1.67%
25,582 $4.78 Million
Q4 2020

Feb 12, 2021

SELL
$130.46 - $172.63 $15,916 - $21,060
-122 Reduced 0.48%
25,163 $4.25 Million
Q2 2020

Aug 14, 2020

SELL
$136.42 - $164.18 $38,061 - $45,806
-279 Reduced 1.09%
25,285 $4.15 Million
Q1 2020

May 14, 2020

SELL
$119.05 - $147.35 $241,671 - $299,120
-2,030 Reduced 7.36%
25,564 $3.55 Million
Q4 2019

Feb 10, 2020

BUY
$106.92 - $132.43 $3,207 - $3,972
30 Added 0.11%
27,594 $3.63 Million
Q1 2019

May 15, 2019

SELL
$111.31 - $131.02 $20,814 - $24,500
-187 Reduced 0.67%
27,564 $3.58 Million
Q3 2018

Nov 13, 2018

BUY
$85.86 - $107.31 $16,055 - $20,066
187 Added 0.68%
27,751 $2.98 Million
Q2 2018

Aug 14, 2018

SELL
$75.7 - $86.88 $4,466 - $5,125
-59 Reduced 0.21%
27,564 $2.35 Million
Q1 2018

May 14, 2018

SELL
$74.21 - $87.6 $48,681 - $57,465
-656 Reduced 2.32%
27,623 $2.14 Million
Q2 2017

Aug 14, 2017

BUY
N/A
28,279
28,279 $2.33 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Logan Capital Management Inc Portfolio

Follow Logan Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logan Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Logan Capital Management Inc with notifications on news.